{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:54:01Z","timestamp":1794664441542,"version":"4.9.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","funder":[{"name":"no funding","award":["0"],"award-info":[{"award-number":["0"]}]},{"name":"Cannot get passed this box","award":["1"],"award-info":[{"award-number":["1"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Microvascular inflammation (MVI) is an important pathological feature of antibody-mediated rejection (AMR). How posttransplant time affects its clinicopathological expression is little understood.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>This retrospective, single-center study screened 3398 kidney transplant biopsies and dichotomized 202 MVI \u2265 2 (Banff glomerulitis + peritubular capillaritis \u2265 2) samples by 9-mo median incidence time for comparison.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>The prevalence of MVI \u2265 2 was 12.4% in transplant kidneys, which failed more frequently than propensity-matched normal controls (n\u2005=\u2005202; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001). Epidemiological risk factors for early MVI \u2265 2 were delayed graft function, prior AMR, and circulating donor-specific antibodies (DSAs+). Prior recipient sensitization occurred in 72.3%. Early MVI \u2265 2 was classified AMR in 65.3% and cellular rejection in 34.7%, and demonstrated excellent functional recovery and graft survival comparable to normal control kidneys. Late MVI \u2265 2 was predicted by younger (18\u2005=\u200529 y) age, female recipient, living-donation, prior methylprednisolone, cyclosporine (versus tacrolimus, levels &lt;5\u2009ng\/mL), absent antiproliferative therapy, and DSA+ using multivariable epidemiological modeling. Nonadherence caused 49.5%, with iatrogenic minimization responsible for 47.5%, usually for recipient infection. Late MVI \u2265 2 was because of AMR in 93.1%, and characterized by greater interstitial fibrosis, tubular atrophy, complement degradation split-product 4d (C4d) staining of peritubular capillaries+, endothelial C4d staining of glomerular capillaries+, transplant glomerulopathy and vasculopathy scores, DSA strength, and graft failure than early MVI \u2265 2 or normal transplant kidneys. Death-censored graft survival in 149 unique MVI \u2265 2 kidneys was independently determined by nonadherence, serum creatinine, proteinuria, DSA+, Banff C4d staining of peritubular capillaries+, and chronic interstitial fibrosis scores. MVI score and time lost significance using multivariable Cox regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>The changing expression of MVI \u2265 2 over time is best explained by differences in underimmunosuppression and microvascular injury from AMR impacting allograft function and survival.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000005224","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T04:00:43Z","timestamp":1727668843000},"page":"376-385","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Early and Late Microvascular Inflammation Have Differing Etiological Causes and Clinical Expression"],"prefix":"10.1097","volume":"109","author":[{"given":"Brian J.","family":"Nankivell","sequence":"first","affiliation":[{"name":"Department of Renal Medicine, Westmead Hospital, Westmead, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seethalakshmi","family":"Viswanathan","sequence":"additional","affiliation":[{"name":"Department of Tissue Pathology and Diagnostic Oncology, ICPMR, Westmead Hospital, Westmead, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"R1-20250124","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.kint.2021.11.029","article-title":"Allorecognition and the spectrum of kidney transplant rejection.","volume":"101","author":"Callemeyn","year":"2022","journal-title":"Kidney Int"},{"key":"R2-20250124","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-mediated rejection of solid-organ allografts.","volume":"379","author":"Loupy","year":"2018","journal-title":"N Engl J Med"},{"key":"R3-20250124","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra0902927","article-title":"Rejection of the kidney allograft.","volume":"363","author":"Nankivell","year":"2010","journal-title":"N Engl J Med"},{"key":"R4-20250124","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients.","volume":"28","author":"Aubert","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R5-20250124","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/TP.0b013e31829434d4","article-title":"Early versus late acute antibody-mediated rejection in renal transplant recipients.","volume":"96","author":"Dorje","year":"2013","journal-title":"Transplantation"},{"key":"R6-20250124","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.kint.2016.10.040","article-title":"Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent\/recurrent versus de novo donor-specific antibodies.","volume":"91","author":"Haas","year":"2017","journal-title":"Kidney Int"},{"key":"R7-20250124","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/ajt.17092","article-title":"Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: differences in timing and intensity but similar mechanisms and outcomes.","volume":"22","author":"Halloran","year":"2022","journal-title":"Am J Transplant"},{"key":"R8-20250124","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.aax4040","article-title":"PIRs mediate innate myeloid cell memory to nonself MHC molecules.","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"R9-20250124","doi-asserted-by":"crossref","first-page":"864730","DOI":"10.3389\/fimmu.2022.864730","article-title":"Microvascular inflammation of the renal allograft: a reappraisal of the underlying mechanisms.","volume":"13","author":"Lebraud","year":"2022","journal-title":"Front Immunol"},{"key":"R10-20250124","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00007890-200103150-00013","article-title":"Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.","volume":"71","author":"Crespo","year":"2001","journal-title":"Transplantation"},{"key":"R11-20250124","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00007890-199001000-00019","article-title":"The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection.","volume":"49","author":"Halloran","year":"1990","journal-title":"Transplantation"},{"key":"R12-20250124","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1523-1755.2005.00085.x","article-title":"Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy.","volume":"67","author":"Ishii","year":"2005","journal-title":"Kidney Int"},{"key":"R13-20250124","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1681\/ASN.V133779","article-title":"Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.","volume":"13","author":"Mauiyyedi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R14-20250124","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-6143.2011.03931.x","article-title":"A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants.","author":"Sis","year":"2012","journal-title":"Am J Transplant"},{"key":"R15-20250124","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-6143.2012.04325.x","article-title":"Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies.","volume":"13","author":"de Kort","year":"2013","journal-title":"Am J Transplant"},{"key":"R16-20250124","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-6143.2010.03364.x","article-title":"Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA).","volume":"11","author":"Loupy","year":"2011","journal-title":"Am J Transplant"},{"key":"R17-20250124","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 Kidney Meeting Report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics.","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"},{"key":"R18-20250124","article-title":"The clinical and pathological significance of microvascular inflammation.","author":"Nankivell","journal-title":"Am J Transplant"},{"key":"R19-20250124","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 Kidney Meeting Report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection.","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transplant"},{"key":"R20-20250124","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.ekir.2022.04.016","article-title":"Glomerular C4d immunoperoxidase in chronic antibody-mediated rejection and transplant glomerulopathy.","volume":"7","author":"Nankivell","year":"2022","journal-title":"Kidney Int Rep"},{"key":"R21-20250124","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/TP.0000000000004071","article-title":"The pathological and clinical diversity of acute vascular rejection in kidney transplantation.","volume":"106","author":"Nankivell","year":"2022","journal-title":"Transplantation"},{"key":"R22-20250124","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/ki.1993.187","article-title":"Capillary deposition of C4d complement fragment and early renal graft loss.","volume":"43","author":"Feucht","year":"1993","journal-title":"Kidney Int"},{"key":"R23-20250124","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/TP.0b013e3182052be8","article-title":"Significance of peritubular capillary, glomerular, and arteriolar C4d staining patterns in paraffin sections of early kidney transplant biopsies.","volume":"91","author":"Kikic","year":"2011","journal-title":"Transplantation"},{"key":"R24-20250124","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1097\/01.ASN.0000025780.03790.0F","article-title":"Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection.","volume":"13","author":"Regele","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R25-20250124","doi-asserted-by":"crossref","first-page":"703457","DOI":"10.3389\/fimmu.2021.703457","article-title":"Non-HLA antibodies and epitope mismatches in kidney transplant recipients with histological antibody-mediated rejection.","volume":"12","author":"Crespo","year":"2021","journal-title":"Front Immunol"},{"key":"R26-20250124","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1111\/j.1523-1755.2000.00390.x","article-title":"Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background.","volume":"58","author":"Dragun","year":"2000","journal-title":"Kidney Int"},{"key":"R27-20250124","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/ajt.16290","article-title":"Adequate tacrolimus exposure modulates the impact of HLA class II molecular mismatch: a validation study in an American cohort.","volume":"21","author":"Davis","year":"2021","journal-title":"Am J Transplant"},{"key":"R28-20250124","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"R29-20250124","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R30-20250124","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1600-6143.2005.01050.x","article-title":"Predicting subsequent decline in kidney allograft function from early surveillance biopsies.","volume":"5","author":"Cosio","year":"2005","journal-title":"Am J Transplant"},{"key":"R31-20250124","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ajt.2022.12.018","article-title":"Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: an orphan category in Banff classification with cytotoxic T and natural killer cell infiltration.","volume":"23","author":"Buxeda","year":"2023","journal-title":"Am J Transplant"},{"key":"R32-20250124","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure.","volume":"9","author":"Einecke","year":"2009","journal-title":"Am J Transplant"},{"key":"R33-20250124","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1038\/s41467-019-13113-5","article-title":"Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants.","volume":"10","author":"Koenig","year":"2019","journal-title":"Nat Commun"},{"key":"R34-20250124","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/TP.0000000000002487","article-title":"Clinical significance of microvascular inflammation in the absence of anti-HLA DSA in kidney transplantation.","volume":"103","author":"Parajuli","year":"2019","journal-title":"Transplantation"},{"key":"R35-20250124","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1681\/ASN.2022040444","article-title":"Banff human organ transplant transcripts correlate with renal allograft pathology and outcome: importance of capillaritis and subpathologic rejection.","volume":"33","author":"Rosales","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"R36-20250124","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/ajt.15074","article-title":"Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: clinical presentation and implications for outcome.","volume":"19","author":"Senev","year":"2019","journal-title":"Am J Transplant"},{"key":"R37-20250124","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody.","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant"},{"key":"R38-20250124","first-page":"314","article-title":"Pathologic characteristics of early or late acute cellular rejection and outcome after kidney transplant.","volume":"12","author":"Wu","year":"2014","journal-title":"Exp Clin Transplant"},{"key":"R39-20250124","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/TP.0000000000000606","article-title":"Long-term kidney allograft survival in patients with transplant glomerulitis.","volume":"99","author":"Nabokow","year":"2015","journal-title":"Transplantation"},{"key":"R40-20250124","doi-asserted-by":"crossref","first-page":"l4923","DOI":"10.1136\/bmj.l4923","article-title":"Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study.","volume":"366","author":"Loupy","year":"2019","journal-title":"BMJ"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T14:02:26Z","timestamp":1737727346000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005224","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]}}}